HULL ANDREW purchased 4947.2% of their position (37.50K shares) of INMED PHARMACEUTICALS INC. on the open market
Open‑market purchase worth $14.6K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 2/22/2024ACC: 0001213900-24-016026
+37.50K
Net shares
Net buyer
$14.6K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
37.50K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+37.50K
Price / share
$0.39
Trade value
$14.63K
% of position
4947.2%
2/21/2024
758.00→38.26K
Total
Net shares
+37.50K
Net value
$14.63K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/21/2024 | P · Purchase | +37.50K | $0.39 | $14.63K | 4947.2% | 758.00 | 38.26K |
| Total | +37.50K | $14.63K | ||||||
Derivative Transactions0
No derivative transactions reported